InVitro International engages in development and commercialization globally of test kits and laboratory services. The company is headquartered in Placentia, California. The Company’s testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its technologies are commercialized through test kits and laboratory services globally. The company operates in various industry segments providing in-vitro (non-animal) consumer, product and environmental safety test methods to customers in the cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation industries. Its Irritection Assay System is a vitro test method which uses changes of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures and product formulations. Its Irritection Assay System consists of an ocular test, Ocular Irritection and dermal test, Dermal Irritection. Corrositex is a non-animal test that determines skin corrosivity.
Invitro International 주요 수익원은 In-vitro (Non-animal) Consumer, Product, and Environmental Safety Test Method이며, 최신 수익 발표에서 수익은 811,290입니다. 지역별로는 United States이 Invitro International의 주요 시장이며, 수익은 513,220입니다.
Invitro International은 수익성이 있나요?
no, 최신 재무제표에 따르면 Invitro International의 순손실은 $0입니다.